Prescription Required
Glimisave MV 3.3 Tablet SR is an oral anti-diabetic medication used to manage type 2 diabetes mellitus. It combines three active ingredients: Glimepiride (3mg), Metformin (500mg), and Voglibose (0.3mg). This combination helps control blood sugar levels by improving insulin secretion, reducing glucose production, and slowing carbohydrate absorption.
Diabetes is a chronic condition that, if left unmanaged, can lead to severe complications like nerve damage, kidney disease, and heart problems. Glimisave MV 3.3 Tablet SR works by addressing multiple aspects of blood sugar regulation, making it an effective treatment option. It is typically prescribed when lifestyle changes and single-drug therapy fail to provide adequate control over blood sugar levels.
This medication is meant to be taken alongside a healthy diet, regular exercise, and weight management. It is not recommended for type 1 diabetes or diabetic ketoacidosis. Patients should take the tablet as per the doctor’s guidance to avoid complications like low blood sugar (hypoglycemia) or gastrointestinal issues.
Avoid alcohol as it may increase the risk of low blood sugar (hypoglycemia) and worsen side effects like dizziness and stomach discomfort.
Consult your doctor before taking this medicine. Uncontrolled diabetes can harm both the mother and baby.
Limited data is available on safety; consult your doctor before use.
Use Glimisave MV 3.3 Tablet with caution in patients with kidney disease; dose adjustment may be required.
Use with caution in patients with liver disease; discuss with your doctor before use.
May cause dizziness or blurred vision due to low blood sugar levels. Avoid driving if affected.
Glimisave MV 3.3 Tablet SR is a combination medication that effectively manages blood sugar levels in diabetes patients. It contains Glimepiride (3mg), a sulfonylurea that stimulates insulin release from the pancreas, Metformin (500mg), a biguanide that reduces glucose production in the liver and improves insulin sensitivity, and Voglibose (0.3mg), an alpha-glucosidase inhibitor that slows carbohydrate breakdown to prevent post-meal blood sugar spikes. Together, these three ingredients provide comprehensive blood sugar control by targeting different mechanisms in the body.
Type 2 Diabetes Mellitus (T2DM) is a condition where the body becomes resistant to insulin or doesn’t produce enough of it. Uncontrolled diabetes can lead to complications like nerve damage, kidney disease, and heart problems. Proper medication, diet, and lifestyle modifications help manage the condition effectively.
Glimisave MV 3.3 Tablet SR is a combination anti-diabetic medication that effectively controls blood sugar by improving insulin function, reducing glucose production, and preventing sugar spikes. When combined with a healthy lifestyle, diet, and exercise, it helps prevent diabetes-related complications. However, it should be used under medical supervision to ensure optimal results and safety.
Content Updated on
Wednesday, 26 Feburary, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA